AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr | ₹275 Cr |
What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹285 Cr |
| Mar2021 | ₹275 Cr |
How is Total Non-Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 3.21 | |
| Mar2024 | ₹41 Cr | -76.99 | |
| Mar2023 | ₹177 Cr | -37.77 | |
| Mar2022 | ₹285 Cr | 3.81 | |
| Mar2021 | ₹275 Cr | - | |
Compare Total Non-Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹35,966.8 Cr | -2.3% | -3.3% | 9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2.3% |
-3.3% |
9% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses